Medtronic has revealed positive data for its VenaSeal closure system, which is designed for the treatment of symptomatic venous reflux.
Results show complete closure of the great saphenous vein in 94.3 percent of patients receiving treatment with the VenaSeal system.
The system minimizes the risk of nerve damage often related to thermal-based procedures and reduces the need for multiple needle sticks, the company says.
The device is available in the U.S., New Zealand, Chile, South Africa, Australia, Canada, Europe, United Arab Emirates, Hong Kong and Turkey. — Anisa Jibrell